Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma

R. Suzuki, T. Hideshima, N. Mimura, J. Minami, H. Ohguchi, S. Kikuchi, Y. Yoshida, G. Gorgun, D. Cirstea, F. Cottini, J. Jakubikova, Y. T. Tai, D. Chauhan, P. G. Richardson, N. C. Munshi, T. Utsugi, K. C. Anderson